| Stage | PEN | % of rev | COR | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $410M | 100.00% | $84.8B | 100.00% | COR ×206.65 |
| Gross profit | $280M | 68.34% | $3.6B | 4.26% | PEN +64.1pp |
| Operating income | $51M | 12.37% | $1.1B | 1.32% | PEN +11.0pp |
| Pre-tax income | $56M | 13.73% | $996M | 1.18% | PEN +12.6pp |
| Net income | $42M | 10.31% | $777M | 0.92% | PEN +9.4pp |
| Stage | PEN | COR | Gap · A − B |
|---|---|---|---|
| Revenue | $410M100.00% | $84.8B100.00% | COR ×206.65 |
| Gross profit | 68.34%$280M | 4.26%$3.6B | PEN +64.1pp |
| Operating income | 12.37%$51M | 1.32%$1.1B | PEN +11.0pp |
| Pre-tax income | 13.73%$56M | 1.18%$996M | PEN +12.6pp |
| Net income |
| 10.31%$42M |
| 0.92%$777M |
| PEN +9.4pp |
None
No disclosed counterparties: PEN.